FDA approves Clinuvel's rare genetic disorder treatment, shares at record high

FDA approves Clinuvel's rare genetic disorder treatment, shares at record high
Reuters: Health
The U.S. Food and Drug Administration approved Australian drugmaker Clinuvel Pharmaceuticals Ltd's treatment for a rare inherited disorder that causes skin damage from exposure to light, sending its shares to a record high on Wednesday.